Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Sanofi SA (ADR) - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
SNY
Nasdaq
2834
https://www.sanofi.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Sanofi SA (ADR)
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
- May 3rd, 2024 2:15 pm
Q1 2024 Kymera Therapeutics Inc Earnings Call
- May 3rd, 2024 3:59 am
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
- May 2nd, 2024 2:01 pm
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
- May 2nd, 2024 11:15 am
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations
- May 2nd, 2024 5:00 am
Sanofi (NASDAQ:SNY) Q1 2024 Earnings Call Transcript
- Apr 30th, 2024 5:22 pm
Press Release: Annual General Meeting of April 30, 2024
- Apr 30th, 2024 4:00 pm
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
- Apr 26th, 2024 3:34 pm
AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge
- Apr 25th, 2024 8:01 pm
Sanofi (SNY) Q1 2024 Earnings Call Transcript
- Apr 25th, 2024 5:45 pm
20 Fastest Growing Health Tech Companies in the World
- Apr 25th, 2024 3:34 pm
Sanofi (SNY) Q1 Earnings In Line, Sales Miss Estimates, Stock Up
- Apr 25th, 2024 3:19 pm
Sanofi Sales, Profit Beat Expectations
- Apr 25th, 2024 7:25 am
UPDATE 2-Sanofi profit slips on generic competition and currency effects
- Apr 25th, 2024 6:05 am
Sanofi profit slips on generic competition and currency effects
- Apr 25th, 2024 5:32 am
Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
- Apr 25th, 2024 5:30 am
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
- Apr 24th, 2024 1:19 pm
SanofiĀ Asks Banks to Pitch for $20 Billion OTC Spinoff
- Apr 24th, 2024 7:50 am
Sanofi (SNY) Rilzabrutinib Shows Benefit in Blood Disorder Study
- Apr 23rd, 2024 4:03 pm
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
- Apr 23rd, 2024 5:00 am
Scroll